CU6 2.98% $5.18 clarity pharmaceuticals ltd

Research/Valuation, page-410

  1. 383 Posts.
    lightbulb Created with Sketch. 19
    From TLX yesterday

    The study utilises copper-64 (64Cu) which isdetectable by Positron Emission Tomography (PET) as a surrogate for actinium-225 (225Ac),enabling a successful proof-of-targeting study as well as predictive dosimetry calculations for futurestudies with 225Ac.

    Interesting use (validation?) of Cu64 in imaging from the competition?
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$5.18
Change
0.150(2.98%)
Mkt cap ! $1.619B
Open High Low Value Volume
$5.05 $5.22 $5.04 $3.900M 758.7K

Buyers (Bids)

No. Vol. Price($)
22 10671 $5.17
 

Sellers (Offers)

Price($) Vol. No.
$5.18 8737 19
View Market Depth
Last trade - 14.47pm 03/07/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.